Presentations we supply
- Injection 3.75 mg
- Injection 11.25 mg
- Injection 22.5 mg
- Injection 45 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for LeuprorelinReference information
Summarised from the product information for Prostap 3 DCS (UK product information). Always follow the product information approved in your own country.
- Active substance
- Leuprorelin
- Pharmacotherapeutic group
- Gonadotrophin-releasing hormone analogues (ATC code L02AE02)
- Authorised uses
- Metastatic prostate cancer
- Locally advanced prostate cancer, as an alternative to surgical castration
- With radiotherapy, in high-risk localised or locally advanced prostate cancer (before or after)
- After radical prostatectomy, in locally advanced prostate cancer at high risk of progression
- Endometriosis, including pain relief and reduction of endometriotic lesions
- Advanced breast cancer in pre- and perimenopausal women suitable for hormonal manipulation
- Early-stage endocrine-responsive breast cancer, adjuvant with tamoxifen or an aromatase inhibitor
- Central precocious puberty in children (girls under 9 years, boys under 10 years)
- Storage (unopened)
- Do not store above 25 °C. Do not refrigerate or freeze. Store in the original container in order to protect from light.
- Shelf life (unopened)
- 3 years (unopened)
- Container and pack
- Dual-chamber pre-filled syringe with 11.25 mg leuprorelin acetate powder and 1 ml solvent, with a 23G safety needle
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Prostap 3 DCS: www.medicines.org.uk